Annexes
Citation:
, . “Annexes”. In: Disease Control Priorities (third edition): Volume , , edited by . Washington, DC: World Bank.
, . “Annexes”. In: Disease Control Priorities (third edition): Volume , , edited by . Washington, DC: World Bank.
Copy to Clipboard
- Annex 1A. Costing the Essential Package for Cardiovascular, Respiratory, and Related Disorders Notes
Chapter 5: Physical Activity for the Prevention of Cardiometabolic Disease
- Annex 5A. Summary of Results on Direct Costs of Inactivity from 18 Studies between 1980–2014
- Annex 5B. Tabulation of the Population Strategies and Interventions to Increase Physical Activity Levels at Multiple Levels of Interventions
- Annex 5C. New Zealand’s Green Prescription (GRx)
Chapter 12: Diabetes: An Update on the Pandemic and Potential Solutions
- Annex 12A. Effectiveness and Quality of Evidence Regarding Diabetes Screening, Prevention, and Treatment Interventions
- Annex 12B. Methodology for Cost-Effectiveness Analyses
- Annex 12C. Studies Reporting Cost-Effectiveness of Diabetes Screening, Prevention, and Treatment Interventions
- Annex 12D. Valuing Interventions—Regional Ceiling Ratios for Benchmarking
- Annex 12E. Gathering and Analyzing Stakeholder Perspectives to Prioritize Interventions
- Annex 13A. Kidney Disease Improving Global Outcomes: Criteria for AKI Severity
- Annex 13B. Kidney Disease Improving Global Outcomes: Stages of Chronic Kidney Disease
- Annex 13C. Selected Population-Based Studies Reporting Prevalence of Chronic Kidney Disease
Chapter 17: Innovations in Community-Based Health for Cardiometabolic Diseases
Chapter 18: Quality Improvement in Vascular Disease Care